Walmart: Ozempic leading to fewer food purchases

Walmart is experiencing less food demand from individuals taking GLP-1s such as Ozempic or Wegovy, Bloomberg reported Oct. 4.

Advertisement

“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” Walmart U.S. CEO John Furner told the publication. “Just less units, slightly less calories.”

According to the report, Walmart and some food manufacturers are studying how weight loss drugs are affecting consumer behaviors and shopping habits. 

Despite the slight decline in food purchases, Walmart executives have said recently that total food, consumables, and health and wellness purchases are still expected to increase percentage-wise through the end of this year, and that individuals taking GLP-1s are more likely to spend more with the retailer on other products.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.